News FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy by Medscape • 2019/05/14 • 0 Comments The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema. FDA Approvals Full Story →